Targeted therapy for cancer:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Oxford Univ. Press
2003
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | xviii, 343 p., Ill., graph. Darst. |
| ISBN: | 0198508964 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019866982 | ||
| 003 | DE-604 | ||
| 005 | 20050829 | ||
| 007 | t | ||
| 008 | 050701s2003 xxkad|| |||| 00||| eng d | ||
| 010 | |a 2003535344 | ||
| 020 | |a 0198508964 |c hbk. : alk. paper |9 0-19-850896-4 | ||
| 035 | |a (OCoLC)50055138 | ||
| 035 | |a (DE-599)BVBBV019866982 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxk |c GB | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC271.I45 | |
| 082 | 0 | |a 616.99406 |2 21 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 084 | |a XH 3300 |0 (DE-625)152889:13129 |2 rvk | ||
| 245 | 1 | 0 | |a Targeted therapy for cancer |c edited by Konstantinos N. Syrigos ... |
| 264 | 1 | |a New York |b Oxford Univ. Press |c 2003 | |
| 300 | |a xviii, 343 p., |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antibodies, Monoclonal | |
| 650 | 4 | |a Cancer |x Molecular aspects | |
| 650 | 4 | |a Cancer |x Treatment | |
| 650 | 4 | |a Gene Therapy | |
| 650 | 4 | |a Immunospecificity | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a Syrigos, Konstantinos N. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013191370&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013191370 | ||
Datensatz im Suchindex
| _version_ | 1804133389593214976 |
|---|---|
| adam_text | List of contributors ix
List of abbreviations xiii
SECTION I
1 The history of targeted therapy for cancer 3
K.D. Bagshawe
2 Preclinical models for the study of targeted therapy 17
Gail Rowlinson Busza
SECTION II
3 Monoclonal antibody targeting therapy: an overview 29
Roslyn J. Francis and Richard H.J. Begent
4 Antibody directed enzyme prodrug therapy (ADEPT) 47
Konstantinos N. Syrigos and Kevin J. Harrington
5 Monoclonal antibody targeted radionuclide therapy 57
Surinder K. Batra, Apollina Goel, Gabriela Pavlinkova, and David Colcher
6 Combined external beam radiotherapy and radioimmunotherapy 76
David Raben and Donald]. Buchsbaum
SECTION III
7 Genetic immunotherapy for cancer 95
Hardev S. Pandha
8 Targeting of cancer gene therapy 111
Kevin J. Harrington and Richard G. Vile
9 Targeted genetic prodrug activation therapy 155
Anne Rigg and Hardev S. Pandha
10 Antisense therapy as a targeted modality 162
Justin Waters and David Cunningham
11 Dendritic cells—targeting the antitumor immune response 187
Alan Melcher, Richard G. Vile, Andrew Bateman, and Kevin J. Harrington
12 Cell carriers for cancer gene therapy: bridging the gap between targeted vectors and systemic
delivery? 204
Rosa Maria Diaz, Heung Chong, and Richard G. Vile
13 Liposomal targeting of cytotoxic drugs 224
Kevin ]. Harrington and Konstantinos N. Syrigos
viii Contents
14 Targeting blood vessels in vivo by using phage display libraries 250
Claudia Vidal, Marina Cardo Vila, Johanna Labdenranta, Wadih Arap, and Renata Pasqualini
SECTION IV
15 Photodynamic therapy 259
Michael R. Hamblin
16 Boron neutron capture therapy: a chemically targeted radiation modality 276
Gerard M. Morris and Jeffrey A. Coderre
SECTION V
17 Cancer immunotherapy directed at growth factor receptors: the ErbB/HER network as
a prototype 291
Michael Sela, Bilha Schecheter, and Yosef Yarden
18 Targeting the metastatic process 317
Lloyd A. Culp, Wen Chang Lin, Nanette R. Kleinman, Priit Kogerman, Raymond Judware,
Carson J. Miller, and Julianne L. Holleran
Index 339
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV019866982 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.I45 |
| callnumber-search | RC271.I45 |
| callnumber-sort | RC 3271 I45 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3200 XH 3300 |
| ctrlnum | (OCoLC)50055138 (DE-599)BVBBV019866982 |
| dewey-full | 616.99406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99406 |
| dewey-search | 616.99406 |
| dewey-sort | 3616.99406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01735nam a2200481zc 4500</leader><controlfield tag="001">BV019866982</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050829 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050701s2003 xxkad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2003535344</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0198508964</subfield><subfield code="c">hbk. : alk. paper</subfield><subfield code="9">0-19-850896-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50055138</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019866982</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.I45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99406</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3300</subfield><subfield code="0">(DE-625)152889:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeted therapy for cancer</subfield><subfield code="c">edited by Konstantinos N. Syrigos ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xviii, 343 p.,</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibodies, Monoclonal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Molecular aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunospecificity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Syrigos, Konstantinos N.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013191370&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013191370</subfield></datafield></record></collection> |
| id | DE-604.BV019866982 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:07:56Z |
| institution | BVB |
| isbn | 0198508964 |
| language | English |
| lccn | 2003535344 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013191370 |
| oclc_num | 50055138 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | xviii, 343 p., Ill., graph. Darst. |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Oxford Univ. Press |
| record_format | marc |
| spelling | Targeted therapy for cancer edited by Konstantinos N. Syrigos ... New York Oxford Univ. Press 2003 xviii, 343 p., Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antibodies, Monoclonal Cancer Molecular aspects Cancer Treatment Gene Therapy Immunospecificity Immunotherapy Neoplasms therapy Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Targeted drug delivery (DE-588)4302415-4 s b DE-604 Syrigos, Konstantinos N. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013191370&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Targeted therapy for cancer Antibodies, Monoclonal Cancer Molecular aspects Cancer Treatment Gene Therapy Immunospecificity Immunotherapy Neoplasms therapy Targeted drug delivery (DE-588)4302415-4 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4302415-4 (DE-588)4073781-0 |
| title | Targeted therapy for cancer |
| title_auth | Targeted therapy for cancer |
| title_exact_search | Targeted therapy for cancer |
| title_full | Targeted therapy for cancer edited by Konstantinos N. Syrigos ... |
| title_fullStr | Targeted therapy for cancer edited by Konstantinos N. Syrigos ... |
| title_full_unstemmed | Targeted therapy for cancer edited by Konstantinos N. Syrigos ... |
| title_short | Targeted therapy for cancer |
| title_sort | targeted therapy for cancer |
| topic | Antibodies, Monoclonal Cancer Molecular aspects Cancer Treatment Gene Therapy Immunospecificity Immunotherapy Neoplasms therapy Targeted drug delivery (DE-588)4302415-4 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Antibodies, Monoclonal Cancer Molecular aspects Cancer Treatment Gene Therapy Immunospecificity Immunotherapy Neoplasms therapy Targeted drug delivery Krebs Medizin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013191370&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT syrigoskonstantinosn targetedtherapyforcancer |